An Open-label, Multicenter, Long-term Phase 3 Study to Evaluate the Safety and Efficacy of Long-term Treatment With SYR-472 in the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control Despite Diet and/or Exercise Therapies or Treatment With an Existing Oral Anti-diabetic Drug Added to Diet and/or Exercise Therapies
An Open-label, Multicenter, Long-term Phase 3 Study to Evaluate the Safety and Efficacy of Long-term Treatment With SYR-472 in the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control Despite Diet and/or Exercise Therapies or Treatment With an Existing Oral Anti-diabetic Drug Added to Diet and/or Exercise Therapies
To evaluate the safety and efficacy of long-term treatment with SYR-472 in diabetic patients.
Inclusion Criteria:
Exclusion Criteria:
Kisarazu-shi, Chiba, Japan
Munakata-shi, Fukuoka, Japan
Koriyama-shi, Fukushima, Japan
Gihu-shi, Gihu, Japan
Fukuyama-shi, Hiroshima, Japan
Eniwa-shi, Hokkaido, Japan
Ishikari-shi, Hokkaido, Japan
Nakagawa-gun, Hokkaido, Japan
Obihiro-shi, Hokkaido, Japan
Sagamihara-shi, Kanagawa, Japan
Tamana-shi, Kumamoto, Japan
Nagawaki-shi, Nagasaki, Japan
Sakai-shi, Osaka, Japan
Ageo-shi, Saitama, Japan
Kawaguchi-shi, Saitama, Japan
Koshigaya-shi, Saitama, Japan
Kuki-shi, Saitama, Japan
Saitama-shi, Saitama, Japan
Suntou-gun, Shizuoka, Japan
Oyama-shi, Tochigi, Japan
Chuo-ku, Tokyo, Japan
Koganei-shi, Tokyo, Japan
Meguro-ku, Tokyo, Japan
Shibuya-ku, Tokyo, Japan
Tama-shi, Tokyo, Japan
Tiyoda-ku, Tokyo, Japan